Navigation Links
Cancer's potential on-off switch
Date:5/15/2014

A team of Boston University School of Medicine (BUSM) researchers have proposed that an "on and off" epigenetic switch could be a common mechanism behind the development of different types of cancer. Epigenetics is the phenomena whereby genetically identical cells express their genes differently, resulting in different physical traits.

Researchers from the Boston University Cancer Center recently published two articles about this in Anticancer Research and Epigenomics.

The current paradigm states that cancer develops from environmental and genetic changes to cancer progenitor cells. These changes are the result of mutations, exposure to toxic substances or hormonal imbalances.

Cancer progression is extremely complex, however. It also is well known that new mutations and the activation of more cancer causing genes occur throughout the development and progression of cancer.

"If we believe that everything in nature occurs in an organized fashion, then it is logical to assume that cancer development cannot be as disorganized as it may seem," said Sibaji Sarkar, PhD, instructor of medicine at BUSM and the articles corresponding author. "There should be a general mechanism that initiates cancer progression from predisposed progenitor cells, which likely involves epigenetic changes."

The existence of this epigenetic switch is indirectly supported by the fact that tumors develop through different stages. When cells rapidly grow during cancer progression, they become stuck in their current stage of development and their cell characteristics do not change. This is the reason that there are so many types of leukemiathe characteristics that a leukemia cell possesses when it begins to rapidly grow and expand are the characteristics that it will keep until the rapid growth stops.

"If we believe that all of the irreversible changes, mutations and effects of carcinogens make cells rapidly grow, then the mechanism that allows cells to stop growing and assume new changes in character must be of great importance," added Sarkar. "The study of cancer progression is key to understanding how cancer cells continue to differentiate."

During cancer progression, there are different stages of rapid growth and differentiation. The control that allows for this switch between growth and differentiation can only be achieved through reversible mechanisms, such as epigenetic changes.

Sarkar and colleagues have previously proposed that epigenetic changes are involved in cancer progenitor cell formation and cancer progression. They also believe that epigenetic changes have the ability to control rapid growth and change of characteristics (different grades/types of tumors).

Sarkar compares the stages of cancer growth to a rocket orbiting in space that is, that an object within an orbit continues to circle a given path, until it is given a signal (or additional fuel) to propel itself into a further orbit. This comparison can be made for cancer progenitor cells and epigenetics. A specific cell continues to grow at a certain stage until it is given a signal in this case, an epigenetic switch that propels it to differentiate into a new orbit, or further differentiated cell.

"While the specific details of the epigenetic code that regulates these changes has not been discovered, the fact that we have a possible explanation for the reversible and ever-changing characteristics for cancer progenitor cells is very exciting," said Sarkar. "Future epigenetics findings hold the key to develop drugs which could possibly kill cancer progenitor cells to reduce cancer relapse and drug-resistant cancer cells."


'/>"/>

Contact: Jenny Eriksen Leary
jenny.eriksen@bmc.org
617-638-6841
Boston University Medical Center
Source:Eurekalert

Related medicine news :

1. HPV-Related Head, Neck Cancers on the Rise
2. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
3. Kinase test may yield big gains for drug-resistant cancers
4. Vitamin E in diet protects against many cancers
5. Infection Causes 1 in 6 Cancers Worldwide: Study
6. Fertilizing bone marrow helps answer why some cancers spread to bones
7. Experimental Drug Helps Fight Some Childhood Cancers, Study Finds
8. Protein RAL associated with aggressive characteristics in prostate, bladder and skin cancers
9. Discovery suggests new combination therapy strategy for basal-like breast cancers
10. Moffitt researcher, colleagues find success with new immune approach to fighting some cancers
11. Gum Disease, HPV May Play Role in Head & Neck Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... 2017 , ... "ProRandom is a set of camera tools that allow video editors to integrate ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , With ProRandom, ... video footage. ProRandom works by using a virtual camera to create the illusion of ...
(Date:1/23/2017)... ... 23, 2017 , ... Gynecology Associates of Gwinnett (GAoG) has ... for women of all ages. The staff of Gynecology Associates of Gwinnett ... from routine health screenings to diagnosing and treating female concerns including menopause, urinary ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... education programs and resources at seafoodnutrition.org/programs and seafoodnutrition.org/resources to assist in teaching ... diet. These resources have been developed for use by nutrition educators and ...
(Date:1/23/2017)... ... ... a time when many people celebrate romance and love by giving cards, candy, flowers or ... present, Atlanta-based Perimeter Plastic Surgery is offering a Valentine’s Day special: Spend $100 ... $50 free. , “A lot of people just buy the more predictable gift of ...
(Date:1/22/2017)... ... January 22, 2017 , ... "Photo Cloud allows FCPX users to add favorited ... with complete ease," said Christina Austin - CEO of Pixel Film Studios. , ... FCPX timeline. Presets include scenes with one, three, four or five focus points. ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... Spain , January 23, 2017 /PRNewswire/ ... biopharmaceutical company focused on treatments for calcification disorders, ... enrolled in the Phase IIb "CaLIPSO Study" clinical ... of cardiovascular calcification (CVC) in end-stage-renal-disease (ESRD) patients ... in the last stage of chronic kidney disease, ...
(Date:1/21/2017)... Research and Markets has announced the addition of the ... (Tumor, Clinical Chemistry, Microbiology, Esoteric), By Type of Lab (Hospital, ... HIV/AIDS etc.), Forecast to 2022" report to their offering. ... US ... clinical lab testing, which has evolved as a major source ...
(Date:1/21/2017)... Jan 20, 2017 Research and Markets has ... & Trends - Technology, Route Of Administration, End User - Forecast ... ... poised to grow at a CAGR of around 7.8% over the ... This industry report analyzes the global markets for Advanced Drug ...
Breaking Medicine Technology: